DN200434, an orally available inverse agonist of estrogen-related receptor γ, induces ferroptosis in sorafenib-resistant hepatocellular carcinoma

Sorafenib, originally identified as an inhibitor of multiple oncogenic kinases, induces ferroptosis in hepatocellular carcinoma (HCC) cells. Several pathways that mitigate sorafenib-induced ferroptosis confer drug resistance; thus strategies that enhance ferroptosis increase sorafenib efficacy. Orph...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong-Ho, Kim, Mi-Jin, Kim, Na-Young, Lee, Seunghyeong, Byun, Jun-Kyu, Yun, Jae Won, Lee, Jaebon, Jin, Jonghwa, Kim, Jina, Chin, Jungwook, Cho, Sung Jin, Lee, In-Kyu, Choi, Yeon-Kyung, Park, Keun-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712702/
https://www.ncbi.nlm.nih.gov/pubmed/36016501
http://dx.doi.org/10.5483/BMBRep.2022.55.11.089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712702/
https://www.ncbi.nlm.nih.gov/pubmed/36016501
http://dx.doi.org/10.5483/BMBRep.2022.55.11.089

Ejemplares similares